Dr. Anna Lee, MD, MPH

Dr. Lee practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Lee's NPI, 1417237058, was assigned on August 26, 2011. Dr. Lee graduated from Mercer University School of Medicine in 2014. Dr. Lee holds Texas license S6434.

Dr. Lee's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Lee's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Texas Children's Hospital. Dmand AI also links Dr. Lee to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Lee is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Lee's licenses on file in 12 states: Texas, Florida, Georgia, Mississippi, Oklahoma, Alabama, Arizona, Louisiana, Tennessee, Washington, New York and Maryland.

Dmand AI lists bone cancer radiation, cancer radiation-upper GI and head & neck cancer radiation among the conditions Dr. Lee treats.

CMS data shows 1,154 Medicare services from Dr. Lee across 14 procedure codes in 2024, for 220 Medicare patients. Medicare paid $57,448 for them.

CMS counts 220 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 69, with 26% women.

In 2024, Dr. Lee wrote 44 Medicare Part D claims for 28 patients. 82% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $762 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Lee for performance year 2024, reported as part of a group. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth.

Dmand AI links 40 papers to Dr. Lee, published from 2018 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Head and Neck Neoplasms, Radiosurgery and Radiotherapy, Intensity-Modulated. Dr. Lee has published most often in Adv Radiat Oncol. Dr. Lee's most frequent co-authors are Jack Phan, MD, PhD, Adam S. Garden, MD and Amy Catherine Moreno, MD.

CMS Open Payments shows 8 general payments to Dr. Lee from 6 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Ion Beam Applications S.A. paid the most, $51.

Dr. Lee graduated from Mercer University School of Medicine in 2014.

Dr. Lee is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.